Back
Apellis Pharmaceuticals Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
51
APLS
Apellis Pharmaceuticals
Last Price:
29.96
Seasonality Move:
22.1%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.4 | Buy |
| 20-day SMA: | 27.8 | Buy |
| 50-day SMA: | 31.23 | Sell |
| 200-day SMA: | 44.21 | Sell |
| 8-day EMA: | 28.61 | Buy |
| 20-day EMA: | 28.43 | Buy |
| 50-day EMA: | 30.68 | Sell |
| 200-day EMA: | 40.64 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 58.06 | Buy |
| Chaikin Money Flow: | 2150169 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.93 - 28.43) | Buy |
| Bollinger Bands (100): | (29.7 - 39.56) | Sell |
Apellis Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 30.02 while APLS 8-day simple moving average is 28.40, which is a Buy signal.
- The stock price of APLS is 30.02 while Apellis Pharmaceuticals 20-day SMA is 27.80, which makes it a Buy.
- Apellis Pharmaceuticals 50-day simple moving average is 31.23 while APLS share price is 30.02, making it a Sell technically.
- APLS stock price is 30.02 and Apellis Pharmaceuticals 200-day simple moving average is 44.21, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Buy
51
Apellis Pharmaceuticals (APLS)
is a Buy
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a Buy
The current Apellis Pharmaceuticals [APLS] share price is $30.02. The Score for APLS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
3.73B
Price in USD:
30.02
Share Volume:
2.52M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
73.80
52-Week Low:
24.34
Buy
51
Apellis Pharmaceuticals (APLS)
is a Buy
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?
The Apellis Pharmaceuticals stock price is 30.02 USD today. -
Will APLS stock go up or go down?
Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Apellis Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is not overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 30.02 while APLS 8-day exponential moving average is 28.61, which is a Buy signal.
- The stock price of APLS is 30.02 while Apellis Pharmaceuticals 20-day EMA is 28.43, which makes it a Buy.
- Apellis Pharmaceuticals 50-day exponential moving average is 30.68 while APLS share price is 30.02, making it a Sell technically.
- APLS stock price is 30.02 and Apellis Pharmaceuticals 200-day simple moving average is 40.64, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
- APLS Moving Average Covergence Divergence (MACD) indicator is -0.4, suggesting Apellis Pharmaceuticals is a Sell
- Apellis Pharmaceuticals Relative Strength Index (RSI) is 58.06, which suggest Apellis Pharmaceuticals is overbought
- The Bollinger Bands (25) for Apellis Pharmaceuticals is (26.93 - 28.43), which suggest Apellis Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Apellis Pharmaceuticals is (29.7 - 39.56), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.